Bipartisan Bill Adding Drugs to Import Controls Reintroduced in Senate
A bill to create a new schedule of drugs, to expand what is covered by import controls, was reintroduced last week by Senate Judiciary Committee Chairman Chuck Grassley, R-Iowa, and Sen. Maggie Hassan, D-N.H.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
The bill is called the Stop Importation and Manufacturing of Synthetic Analogues (SIMSA) Act.
"America’s scheduling system is inefficient and outdated, and our law enforcement officers are struggling to keep pace with emerging drug threats," Grassley said in the press release. "The SIMSA Act would provide much-needed adaptability to get ahead of bad actors and their deadly knockoffs."
The new schedule would be called Schedule A, and would apply to analogues. If chemicals are mislabeled that should have been on Schedule A, that would be a crime.